Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

CYTK holding history

Cytokinetics Inc in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CYTK overviewAll 13F holders of CYTKFull Q2 2026 holdings

Shares (Q2 2026)
640,945
Value
$54.6M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of CYTK by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026640,945$54.6M<0.1%−458,913−41.7%ReducedHolders
Q1 20261,099,858$72.5M0.1%−63,079−5.4%ReducedHolders
Q4 20251,162,937$73.9M0.1%−223,128−16.1%ReducedHolders
Q3 20251,386,065$76.2M0.1%+87,456+6.7%AddedHolders
Q2 20251,298,609$42.9M<0.1%+148,095+12.9%AddedHolders
Q1 20251,150,514$46.2M<0.1%−221,131−16.1%ReducedHolders
Q4 20241,371,645$64.5M0.1%+434,454+46.4%AddedHolders
Q3 2024937,191$49.5M0.1%+78,218+9.1%AddedHolders
Q2 2024858,973$46.5M<0.1%+298,071+53.1%AddedHolders
Q1 2024560,902$39.3M<0.1%+288,309+105.8%AddedHolders
Q4 2023272,593$22.8M<0.1%−959,231−77.9%ReducedHolders
Q3 20231,231,824$36.3M<0.1%+331,835+36.9%AddedHolders
Q2 2023899,989$29.4M<0.1%+899,989NewHolders
Q1 20230$00.0%−80,263−100.0%Sold outHolders
Q4 202280,263$3.68M<0.1%−417,392−83.9%ReducedHolders
Q3 2022497,655$24.1M<0.1%−4,145,172−89.3%ReducedHolders
Q2 20224,642,827$182.4M0.2%+4,370,177+1,602.9%AddedHolders
Q1 2022272,650$10.0M<0.1%+240,717+753.8%AddedHolders
Q4 202131,933$1.46M<0.1%−261,674−89.1%ReducedHolders
Q3 2021293,607$10.5M<0.1%+206,533+237.2%AddedHolders
Q2 202187,074$1.72M<0.1%−234,642−72.9%ReducedHolders
Q1 2021321,716$7.48M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.